Clinical Trial Update: Blood Biomarker Signature in Glioma

View source ↗

Summary

The clinical trial investigating a blood biomarker signature in glioma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Snippet

Sponsor: Cancer Trials Ireland | Conditions: Glioma of Brain | Status: TERMINATED